An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries

BACKGROUND: chemotherapy-induced nausea and vomiting (CINV) has been commonly reported as one of the most distressing adverse effects among treated patients with cancer. Inadequately treated, CINV can lead to increased resource utilization and severely impair patients’ daily functioning and quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Turini, Marco, Piovesana, Vittoria, Ruffo, Pierfrancesco, Ripellino, Claudio, Cataldo, Nazarena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/
https://www.ncbi.nlm.nih.gov/pubmed/26322114
http://dx.doi.org/10.7573/dic.212285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/
https://www.ncbi.nlm.nih.gov/pubmed/26322114
http://dx.doi.org/10.7573/dic.212285

Ejemplares similares